The opioid-induced constipation (OIC) market is booming, projected to exceed $3.5 billion by 2033, driven by rising opioid use and innovative treatments. Learn about market trends, key players (Bausch Health, Merck), and regional growth forecasts in this in-depth analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.